The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use
- PMID: 29694292
- PMCID: PMC10397681
- DOI: 10.18553/jmcp.2018.24.5.416
The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use
Abstract
Background: In 2007, the Centers for Medicare & Medicaid Services (CMS) instituted a star rating system using performance outcome measures to assess Medicare Advantage Prescription Drug (MAPD) and Prescription Drug Plan (PDP) providers.
Objective: To assess the relationship between 2 performance outcome measures for Medicare insurance providers, comprehensive medication reviews (CMRs), and high-risk medication use.
Methods: This cross-sectional study included Medicare Part C and Part D performance data from the 2014 and 2015 calendar years. Performance data were downloaded per Medicare contract from the CMS. We matched Medicare insurance provider performance data with the enrollment data of each contract. Mann Whitney U and Spearman rho tests and a hierarchical linear regression model assessed the relationship between provider characteristics, high-risk medication use, and CMR completion rate outcome measures.
Results: In 2014, an inverse correlation between CMR completion rate and high-risk medication use was identified among MAPD plan providers. This relationship was further strengthened in 2015. No correlation was detected between the CMR completion rate and high-risk medication use among PDP plan providers in either year. A multivariate regression found an inverse association with high-risk medication use among MAPD plan providers in comparison with PDP plan providers in 2014 (beta = -0.358, P < 0.001) and 2015 (beta = -0.350, P < 0.001), the CMR completion rate in 2015 (beta = -0.221, P < 0.001), and enrollee population size in 2015 (beta = -0.203, P = 0.001).
Conclusions: This study found that MAPD plan providers and higher CMR completion rates were associated with lower use of high-risk medications among beneficiaries.
Disclosures: No outside funding supported this study. Silva Almodovar reports a fellowship funded by SinfoniaRx, Tucson, Arizona, during the time of this study. The other authors have nothing to disclose.
Conflict of interest statement
No outside funding supported this study. Silva Almodovar reports a fellowship funded by SinfoniaRx, Tucson, Arizona, during the time of this study. The other authors have nothing to disclose.
Similar articles
-
Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.J Manag Care Spec Pharm. 2016 Jul;22(7):796-800. doi: 10.18553/jmcp.2016.22.7.796. J Manag Care Spec Pharm. 2016. PMID: 27348280 Free PMC article.
-
Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.J Manag Care Spec Pharm. 2017 Jan;23(1):13-21. doi: 10.18553/jmcp.2017.23.1.13. J Manag Care Spec Pharm. 2017. PMID: 28025924 Free PMC article. Clinical Trial.
-
Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.J Manag Care Spec Pharm. 2017 Jan;23(1):22-26. doi: 10.18553/jmcp.2017.23.1.22. J Manag Care Spec Pharm. 2017. PMID: 28025922 Free PMC article.
-
Centers for Medicare and Medicaid Services Support for Medication Therapy Management (Enhanced Medication Therapy Management): Testing Strategies for Improving Medication Use Among Beneficiaries Enrolled in Medicare Part D.Clin Geriatr Med. 2017 May;33(2):153-164. doi: 10.1016/j.cger.2017.01.001. Epub 2017 Feb 14. Clin Geriatr Med. 2017. PMID: 28364988 Review.
-
Impact of star ratings on Medicare health plan enrollment: A systematic literature review.J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4):989-997.e3. doi: 10.1016/j.japh.2023.03.009. Epub 2023 Apr 3. J Am Pharm Assoc (2003). 2023. PMID: 37019381
Cited by
-
Implementation process for comprehensive medication review in the community pharmacy setting.J Am Pharm Assoc (2003). 2019 Nov-Dec;59(6):836-841.e2. doi: 10.1016/j.japh.2019.07.007. Epub 2019 Aug 9. J Am Pharm Assoc (2003). 2019. PMID: 31405803 Free PMC article.
-
A Research Partnership to Enhance Postgraduate Pharmacy Residency Training Outcomes.Pharmacy (Basel). 2020 Jul 31;8(3):134. doi: 10.3390/pharmacy8030134. Pharmacy (Basel). 2020. PMID: 32751792 Free PMC article.
-
Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.J Manag Care Spec Pharm. 2019 May;25(5):573-577. doi: 10.18553/jmcp.2019.25.5.573. J Manag Care Spec Pharm. 2019. PMID: 31039057 Free PMC article.
-
Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region.J Manag Care Spec Pharm. 2020 Oct;26(10):1309-1316. doi: 10.18553/jmcp.2020.26.10.1309. J Manag Care Spec Pharm. 2020. PMID: 32996396 Free PMC article.
-
Home care nurses' management of high-risk medications: a cross-sectional study.J Pharm Policy Pract. 2022 Nov 21;15(1):88. doi: 10.1186/s40545-022-00476-2. J Pharm Policy Pract. 2022. PMID: 36414977 Free PMC article.
References
-
- Academy of Managed Care Pharmacy, American Pharmacists Association . Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality. J Am Pharm Assoc (2003). 2014;54(3):228-40. - PubMed
-
- Centers for Medicare & Medicaid . Fact sheet - 2017 star ratings. In: 2017 star rating and display measures. 2017. Available at: https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrug.... Accessed March 31, 2018.
-
- Centers for Medicare & Medicaid Services . Medicare 2016 Part C & D star rating technical notes. In: 2016 star ratings and display measures. March 24, 2017. Available at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrug.... Accessed March 31, 2018.
-
- Centers for Medicare & Medicaid Services . Medicare 2017 Part C & D star rating technical notes. In: 2017 star rating and display measures. March 24, 2017. Available at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrug.... Accessed March 31, 2018.
-
- Centers for Medicare & Medicaid Services . Announcement of calendar year (CY) 2017 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. April 24, 2016. Available at: https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Dow.... Accessed March 31, 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical